{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T20:38:37Z","timestamp":1769546317774,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"26","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/QUI\/50006\/2019"],"award-info":[{"award-number":["UID\/QUI\/50006\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00216-019-02076-7","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T10:02:31Z","timestamp":1566468151000},"page":"7005-7013","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel GC-MS methodology to evaluate aromatase activity in human placental microsomes: a comparative study with the standard radiometric assay"],"prefix":"10.1007","volume":"411","author":[{"given":"Tiago V.","family":"Augusto","sequence":"first","affiliation":[]},{"given":"Sara C.","family":"Cunha","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Amaral","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 O.","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Elisi\u00e1rio Tavares","family":"da Silva","sequence":"additional","affiliation":[]},{"given":"Fernanda F. M.","family":"Roleira","sequence":"additional","affiliation":[]},{"given":"Nat\u00e9rcia","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Georgina","family":"Correia-da-Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"issue":"11","key":"2076_CR1","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1021\/acs.jmedchem.5b01281","volume":"59","author":"D Ghosh","year":"2016","unstructured":"Ghosh D, Lo J, Egbuta C. Recent progress in the discovery of next generation inhibitors of aromatase from the structure-function perspective. J Med Chem. 2016;59(11):5131\u201348. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01281 .","journal-title":"J Med Chem"},{"issue":"3","key":"2076_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1210\/edrv-15-3-342","volume":"15","author":"ER Simpson","year":"1994","unstructured":"Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev. 1994;15(3):342\u201355. https:\/\/doi.org\/10.1210\/edrv-15-3-342 .","journal-title":"Endocr Rev"},{"issue":"4\u20135","key":"2076_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jsbmb.2009.09.012","volume":"118","author":"D Ghosh","year":"2010","unstructured":"Ghosh D, Griswold J, Erman M, Pangborn W. X-ray structure of human aromatase reveals an androgen-specific active site. J Steroid Biochem Mol Biol. 2010;118(4\u20135):197\u2013202. https:\/\/doi.org\/10.1016\/j.jsbmb.2009.09.012 .","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"7226","key":"2076_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nature07614","volume":"457","author":"D Ghosh","year":"2009","unstructured":"Ghosh D, Griswold J, Erman M, Pangborn W. Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature. 2009;457(7226):219\u201323. https:\/\/doi.org\/10.1038\/nature07614 .","journal-title":"Nature"},{"issue":"4","key":"2076_CR5","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1530\/ERC-13-0099.","volume":"20","author":"PE Lonning","year":"2013","unstructured":"Lonning PE, Eikesdal HP. Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved. Endocr Relat Cancer. 2013;20(4):R183\u2013201. https:\/\/doi.org\/10.1530\/ERC-13-0099.","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"2076_CR6","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1002\/j.1460-2075.1996.tb00571.x","volume":"15","author":"G Bunone","year":"1996","unstructured":"Bunone G, Briand PA, Miksicek RJ, Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 1996;15(9):2174\u201383.","journal-title":"EMBO J"},{"key":"2076_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jsbmb.2015.07.018","volume":"161","author":"HJ Chan","year":"2016","unstructured":"Chan HJ, Petrossian K, Chen S. Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells. J Steroid Biochem Mol Biol. 2016;161:73\u201383. https:\/\/doi.org\/10.1016\/j.jsbmb.2015.07.018 .","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"2076_CR8","doi-asserted-by":"publisher","first-page":"R283","DOI":"10.1530\/ERC-17-0425","volume":"25","author":"TV Augusto","year":"2018","unstructured":"Augusto TV, Correia-da-Silva G, Rodrigues CMP, Teixeira N, Amaral C. Acquired resistance to aromatase inhibitors: where we stand! Endocr Relat Cancer. 2018;25(5):R283\u2013301. https:\/\/doi.org\/10.1530\/ERC-17-0425 .","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"2076_CR9","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/annonc\/mdy192","volume":"29","author":"F Cardoso","year":"2018","unstructured":"Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, Andre F, et al. 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)dagger. Ann Oncol. 2018;29(8):1634\u201357. https:\/\/doi.org\/10.1093\/annonc\/mdy192 .","journal-title":"Ann Oncol"},{"issue":"1","key":"2076_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2147\/TCRM.S1566","volume":"4","author":"JM Nabholtz","year":"2008","unstructured":"Nabholtz JM. Long-term safety of aromatase inhibitors in the treatment of breast cancer. Ther Clin Risk Manag. 2008;4(1):189\u2013204.","journal-title":"Ther Clin Risk Manag"},{"issue":"17","key":"2076_CR11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/jnci\/djr242","volume":"103","author":"E Amir","year":"2011","unstructured":"Amir E, Seruga B, Niraula S, Carlsson L, Ocana A. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst. 2011;103(17):1299\u2013309. https:\/\/doi.org\/10.1093\/jnci\/djr242 .","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2076_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/annonc\/mdw673","volume":"28","author":"F Khosrow-Khavar","year":"2017","unstructured":"Khosrow-Khavar F, Filion KB, Al-Qurashi S, Torabi N, Bouganim N, Suissa S, et al. Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials. Ann Oncol. 2017;28(3):487\u201396. https:\/\/doi.org\/10.1093\/annonc\/mdw673 .","journal-title":"Ann Oncol"},{"key":"2076_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jsbmb.2017.04.002","volume":"171","author":"C Amaral","year":"2017","unstructured":"Amaral C, Varela CL, Mauricio J, Sobral AF, Costa SC, Roleira FMF, et al. Anti-tumor efficacy of new 7alpha-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells. J Steroid Biochem Mol Biol. 2017;171:218\u201328. https:\/\/doi.org\/10.1016\/j.jsbmb.2017.04.002 .","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"2076_CR14","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s10495-013-0879-6.","volume":"18","author":"C Amaral","year":"2013","unstructured":"Amaral C, Varela C, Borges M, Tavares da Silva E, Roleira FMF, Correia-da-Silva G, et al. Steroidal aromatase inhibitors inhibit growth of hormone-dependent breast cancer cells by inducing cell cycle arrest and apoptosis. Apoptosis. 2013;18(11):1426\u201336. https:\/\/doi.org\/10.1007\/s10495-013-0879-6.","journal-title":"Apoptosis"},{"issue":"14","key":"2076_CR15","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.steroids.2008.07.001","volume":"73","author":"MM Cepa","year":"2008","unstructured":"Cepa MM, Tavares da Silva EJ, Correia-da-Silva G, Roleira FM, Teixeira NA. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors. Steroids. 2008;73(14):1409\u201315. https:\/\/doi.org\/10.1016\/j.steroids.2008.07.001 .","journal-title":"Steroids"},{"issue":"12","key":"2076_CR16","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1016\/j.bmc.2016.04.056","volume":"24","author":"CL Varela","year":"2016","unstructured":"Varela CL, Amaral C, Correia-da-Silva G, Costa SC, Carvalho RA, Costa G, et al. Exploring new chemical functionalities to improve aromatase inhibition of steroids. Bioorg Med Chem. 2016;24(12):2823\u201331. https:\/\/doi.org\/10.1016\/j.bmc.2016.04.056 .","journal-title":"Bioorg Med Chem"},{"issue":"1\u20133","key":"2076_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0039-128X(83)90068-5","volume":"50","author":"RE Steele","year":"1987","unstructured":"Steele RE, Mellor LB, Sawyer WK, Wasvary JM, Browne LJ. In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A. Steroids. 1987;50(1\u20133):147\u201361.","journal-title":"Steroids"},{"issue":"15","key":"2076_CR18","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1021\/jm00015a006","volume":"38","author":"JM O\u2019Reilly","year":"1995","unstructured":"O\u2019Reilly JM, Li N, Duax WL, Brueggemeier RW. Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase. J Med Chem. 1995;38(15):2842\u201350.","journal-title":"J Med Chem"},{"issue":"3","key":"2076_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3109\/14756369509021485","volume":"9","author":"VC Njar","year":"1995","unstructured":"Njar VC, Grun G, Hartmann RW. Evaluation of 6,7-aziridinyl steroids and related compounds as inhibitors of aromatase (P-450arom). J Enzym Inhib. 1995;9(3):195\u2013202.","journal-title":"J Enzym Inhib"},{"issue":"7","key":"2076_CR20","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1021\/acs.jmedchem.9b00157","volume":"62","author":"FMF Roleira","year":"2019","unstructured":"Roleira FMF, Varela C, Amaral C, Costa SC, Correia-da-Silva G, Moraca F, et al. C-6alpha- vs C-7alpha-substituted steroidal aromatase inhibitors: which is better? Synthesis, biochemical evaluation, docking studies, and structure-activity relationships. J Med Chem. 2019;62(7):3636\u201357. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00157 .","journal-title":"J Med Chem"},{"issue":"1","key":"2076_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1530\/REP-17-0472","volume":"155","author":"EL Legacki","year":"2018","unstructured":"Legacki EL, Corbin CJ, Ball BA, Scoggin KE, Stanley SD, Conley AJ. Steroidogenic enzyme activities in the pre- and post-parturient equine placenta. Reproduction. 2018;155(1):51\u20139. https:\/\/doi.org\/10.1530\/REP-17-0472 .","journal-title":"Reproduction"},{"issue":"17","key":"2076_CR22","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/S0021-9258(20)79736-X","volume":"249","author":"EA Thompson Jr","year":"1974","unstructured":"Thompson EA Jr, Siiteri PK. The involvement of human placental microsomal cytochrome P-450 in aromatization. J Biol Chem. 1974;249(17):5373\u20138.","journal-title":"J Biol Chem"},{"issue":"14","key":"2076_CR23","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1007\/s00216-014-7764-1","volume":"406","author":"MH Park","year":"2014","unstructured":"Park MH, Kim IS, Dong MS, Yoo HH. Development of an LC-MS\/MS method for aromatase inhibitor screening. Anal Bioanal Chem. 2014;406(14):3443\u20139. https:\/\/doi.org\/10.1007\/s00216-014-7764-1 .","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"2076_CR24","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1248\/bpb.24.564","volume":"24","author":"M Numazawa","year":"2001","unstructured":"Numazawa M, Yoshimura A, Nagaoka M. Gas chromatography-mass spectrometric determination of activity of human placental aromatase using 16alpha-hydroxyandrostenedione as a substrate. Biol Pharm Bull. 2001;24(5):564\u20136.","journal-title":"Biol Pharm Bull"},{"issue":"20","key":"2076_CR25","doi-asserted-by":"publisher","first-page":"6379","DOI":"10.1021\/jm050129p","volume":"48","author":"MM Cepa","year":"2005","unstructured":"Cepa MM, Tavares da Silva EJ, Correia-da-Silva G, Roleira FM, Teixeira NA. Structure-activity relationships of new A,D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation. J Med Chem. 2005;48(20):6379\u201385. https:\/\/doi.org\/10.1021\/jm050129p .","journal-title":"J Med Chem"},{"issue":"8","key":"2076_CR26","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1021\/jm300262w","volume":"55","author":"C Varela","year":"2012","unstructured":"Varela C, Tavares da Silva EJ, Amaral C, Correia da Silva G, Baptista T, Alcaro S, et al. New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation. J Med Chem. 2012;55(8):3992\u20134002. https:\/\/doi.org\/10.1021\/jm300262w .","journal-title":"J Med Chem"},{"issue":"7","key":"2076_CR27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.steroids.2013.02.016","volume":"78","author":"CL Varela","year":"2013","unstructured":"Varela CL, Amaral C, Correia-da-Silva G, Carvalho RA, Teixeira NA, Costa SC, et al. Design, synthesis and biochemical studies of new 7alpha-allylandrostanes as aromatase inhibitors. Steroids. 2013;78(7):662\u20139. https:\/\/doi.org\/10.1016\/j.steroids.2013.02.016 .","journal-title":"Steroids"},{"issue":"10","key":"2076_CR28","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0039-128X(01)00108-8","volume":"66","author":"DD Heidrich","year":"2001","unstructured":"Heidrich DD, Steckelbroeck S, Klingmuller D. Inhibition of human cytochrome P450 aromatase activity by butyltins. Steroids. 2001;66(10):763\u20139.","journal-title":"Steroids"},{"key":"2076_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.talanta.2012.12.045","volume":"107","author":"C Amaral","year":"2013","unstructured":"Amaral C, Cunha SC, Fernandes JO, Tavares da Silva E, Roleira FM, Teixeira N, et al. Development of a new gas chromatography-mass spectrometry (GC-MS) methodology for the evaluation of 5alpha-reductase activity. Talanta. 2013;107:154\u201361. https:\/\/doi.org\/10.1016\/j.talanta.2012.12.045 .","journal-title":"Talanta"},{"issue":"1","key":"2076_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03067319.2019.1566955","volume":"99","author":"SVM de Sa","year":"2019","unstructured":"de Sa SVM, Fernandes JO, Cunha SC. In situ acetylation dispersive liquid-liquid microextraction followed by gas chromatography-mass spectrometry for the simultaneous determination of musks, triclosan and methyl-triclosan in wastewaters. Int J Environ Anal Chem. 2019;99(1):1\u201315. https:\/\/doi.org\/10.1080\/03067319.2019.1566955 .","journal-title":"Int J Environ Anal Chem"},{"key":"2076_CR31","unstructured":"Administration FaD. Bioanalytical method validation guidance for industry 2018."},{"issue":"4","key":"2076_CR32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0960-0760(96)00064-7","volume":"58","author":"M Dukes","year":"1996","unstructured":"Dukes M, Edwards PN, Large M, Smith IK, Boyle T. The preclinical pharmacology of \u201cArimidex\u201d (anastrozole; ZD1033)--a potent, selective aromatase inhibitor. J Steroid Biochem Mol Biol. 1996;58(4):439\u201345.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"2076_CR33","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/0960-0760(90)90460-3","volume":"37","author":"AS Bhatnagar","year":"1990","unstructured":"Bhatnagar AS, Hausler A, Schieweck K, Lang M, Bowman R. Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor. J Steroid Biochem Mol Biol. 1990;37(6):1021\u20137.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2076_CR34","unstructured":"Agency EDSP-USEP. Aromatase assay (human recombinant) OCSPP guideline 890.1200 2011."}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-019-02076-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-019-02076-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-019-02076-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T06:00:21Z","timestamp":1610863221000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-019-02076-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":34,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["2076"],"URL":"https:\/\/doi.org\/10.1007\/s00216-019-02076-7","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"11 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human term placental tissues were obtained under informed consent and collected after birth. All the procedures concerning human placental handling were performed after approval of the Ethical Committee of Centro Materno Infantil do Norte, Centro Hospitalar do Porto, Portugal.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}